Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox Completes Enrolment of NCX 4251 Phase 2 Trial with Top-Line Results on Track for Q4 2019

September 27, 2019

View Press Release Corporate presentation Contact us
Previous